QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 clover-health-investments-q3-eps-005-misses-003-estimate-sales-496650m-beat-471091m-estimate

Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.05) per share which missed the analyst consensus estim...

 top-stocks-with-earnings-this-week-joby-ionq-amd-and-more

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Fr...

 clover-health-announces-departure-of-chelsea-clinton-from-board-of-directors-effective-october-31-2025

Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company") today annou...

 spac-king-chamath-palihapitiya-tells-retail-investors-to-stay-away-from-his-new-spac

Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why.

 chamath-palihapitiya-returns-to-spacs-past-18-deals-investments-average-loss-of-14

Chamath Palihapitiya is back with a new SPAC. Many investors will remember past SPACs the investor was involved with and the po...

 spac-king-chamath-palihapitiya-returns-with-250-million-american-exceptionalism-deal-targeting-ai-energy-defense

Venture capitalist Chamath Palihapitiya, once dubbed the "SPAC King," is returning to Wall Street with a new blank-chec...

 ubs-maintains-neutral-on-clover-health-investments-lowers-price-target-to-3

UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and lowers the price target from ...

 correction-clover-health-reaffirms-fy25-insurance-revenue-outlook-180b-1875b

Financial GuidanceFor full-year 2025, Clover Health is updating its guidance as follows:Current 2025 GuidancePrevious 2025 Guid...

 clover-health-investments-q2-eps-002-beats-003-estimate-sales-477620m-beat-468296m-estimate

Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimat...

Core News & Articles

https://www.wsj.com/health/healthcare/medicare-part-d-drug-plan-premiums-set-to-rise-16ef919c

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION